Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of NASDAQ:CALA opened at $0.01 on Tuesday. Calithera Biosciences has a one year low of $0.01 and a one year high of $0.50. The firm has a 50 day simple moving average of $0.02 and a 200 day simple moving average of $0.02.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.